Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001214659-25-014073·PMV Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
PMV PHARMACEUTICALS INC
Common Stock, par value $0.00001 per share · CUSIP: 69353Y103
Event date: 2025-09-16
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TANG CAPITAL MANAGEMENT, LLC
Shares: 4,720,357.00 · Class: 8.9%
- KEVIN TANG
Shares: 4,720,357.00 · Class: 8.9%
- TANG CAPITAL PARTNERS, LP
Shares: 2,654,728.00 · Class: 5.0%
- TANG CAPITAL PARTNERS INTERNATIONAL, LP
Shares: 2,065,629.00 · Class: 3.9%
- TANG CAPITAL PARTNERS III, INC
Shares: 0.00 · Class: 0.0%
- TANG CAPITAL PARTNERS IV, INC
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-014073
- Form type
- SCHEDULE 13G
- Filer
- PMV Pharmaceuticals, Inc.
- CIK
- CIK 1699382
- Filed
- Sep 23, 2025
- Reporting period
- Sep 16, 2025
- Description
- Schedule 13G beneficial ownership